JAN. 25, 2018 - "In the fourth quarter we prepared the organization to fully leverage the improved position for Zubsolv® in the US"
Opioid abuse is today the most common cause of death from drug overdose. The problem is greatest in the US, where just over 60,000 Americans died of an overdose in 2016, mainly caused by use of opioids. Orexo’s key market is the US market for the treatment of opioid dependence.
FEBRUARY 21 2018 Listen to CEO Nikolaj Sørensen in a brief interview about the latest development for Zubsolv in the US, market competition and strategic priorities. On Youtube we also display a presentation of 20 minutes where the latest development is presented.